Skip to content
Research/Cognitive Enhancement/Low-Dose Aripiprazole

Low-Dose Aripiprazole

Aripiprazole, typically used as an antipsychotic, is being explored at low doses for potential cognitive enhancement and mood stabilization. Its mechanism involves partial agonism of dopamine D2 and serotonin 5-HT1A receptors, which may support cognitive function and emotional regulation. This could be relevant for longevity by potentially improving mental health and cognitive resilience.

Intelligence Profile

Safety Profile

Safety Profile for Low-Dose Aripiprazole

Known Side Effects

Low-dose aripiprazole has not been widely studied specifically for differential side effects compared to standard doses, leaving some uncertainty. General side effects of aripiprazole can include:

  • Weight Gain: Common in antipsychotic medications, though less pronounced with aripiprazole.
  • Sedation: Noted, particularly in pediatric populations.
  • Gastrointestinal Issues: Such as nausea.

Contraindications

Evidence regarding specific contraindications for low-dose aripiprazole is limited. Generally, aripiprazole should be used cautiously or avoided in individuals with:

  • Allergy to aripiprazole or any components of the formulation.
  • Severe cardiovascular issues: Due to potential for orthostatic hypotension.

Drug Interactions

While specific data for low-dose interactions is limited, aripiprazole interacts with:

  • CYP3A4 and CYP2D6 inhibitors/inducers: Such as ketoconazole or fluoxetine, which can alter its plasma levels.
  • Other CNS medications: Combined sedative effects with other antipsychotics or antidepressants.

Populations to Avoid Use

Evidence is thin regarding populations that specifically should avoid low-dose aripiprazole, but general caution is advised for:

  • Pregnant Women: Concerns arise from animal studies showing skeletal ossification changes. Notably, the study was conducted in rats, and human applicability requires cautious interpretation.
  • Liver Impairment: The potential for liver failure is noted in overdose, suggesting caution in hepatic-compromised patients.

Additional Considerations

Safety in special populations like children or adolescents has some supportive data indicating short-term sedative effects and dosing concerns. Long-term safety in these groups needs more exploration.

Disclaimer

This overview is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional for personalized medical guidance.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.